Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
EMBO Molecular Medicine|May 2, 2022
Caspase-8 in endothelial cells maintains gut homeostasis and prevents small bowel inflammation in miceNathalie Tisch, Carolin Mogler, Ana Stojanovic, et al.
Arthritis Research & Therapy|November 22, 2015
Peripheral blood natural killer cell percentages in granulomatosis with polyangiitis correlate with disease inactivity and stageWolfgang Merkt, Prisca Sturm, Felix Lasitschka, et al.
Oncoimmunology|September 17, 2020
Human innate immune cell crosstalk induces melanoma cell senescenceFelix Funck, Jens Pahl, Lenka Kyjacova, et al.
Plos One|February 27, 2015
Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetesRami Yossef, Chamutal Gur, Avishai Shemesh, et al.
International Journal of Cancer|December 18, 2008
Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cellsNicole Schwinn, Daria Vokhminova, Antje Sucker, et al.
Frontiers in Immunology|June 8, 2018
NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell DeathAvishai Shemesh, Kiran Kundu, Refael Peleg, et al.
Cancer Research|May 1, 2014
Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30Eva Schlecker, Nathalie Fiegler, Annette Arnold, et al.
Blood|June 11, 2011
Btk is a positive regulator in the TREM-1/DAP12 signaling pathwayTereza Ormsby, Eva Schlecker, Janina Ferdin, et al.
Plos One|May 15, 2008
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Plos Pathogens|September 9, 2011
Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutininMostafa Jarahian, Manuela Fiedler, André Cohnen, et al.
Pageof 11